Short Summary
LiNA Medical AG, proprietor of European Patent EP 2 593 025 B1 relating to a laparoscopic morcellator, filed an application for preservation of evidence and inspection against Tonglu Qianyan Medtech Co., Ltd. before the Düsseldorf Local Division. The Applicant sought measures at the Defendant's exhibition booth at the MEDICA trade fair in Düsseldorf, suspecting that the Defendant's exhibited disposable morcellator was a slavish copy of LiNA's Xcise™ product and infringed the patent. The Court granted the application, ordering an inspection and preservation of evidence procedure to be carried out by an independent expert, subject to confidentiality measures.
Detailed Summary
This case concerns an application for preservation of evidence and inspection filed by LiNA Medical AG against Tonglu Qianyan Medtech Co., Ltd. before the Düsseldorf Local Division of the Unified Patent Court, issued on 18 November 2025.
The Applicant, LiNA Medical AG, is the registered proprietor of European Patent EP 2 593 025 B1, titled "Laparoscopic morcellator." The patent was filed on 6 July 2011 (claiming priority from US 836 957 of 15 July 2010) and was granted on 10 December 2014. It is currently in force in Germany, France, and the United Kingdom. The patent claims a disposable laparoscopic morcellator for removing tissue through a small incision, featuring an elongated cylinder with a cutting edge, a trocar, a housing, a motor, a battery, and a switch mechanism. LiNA Medical manufactures the LiNA Xcise™, a ready-to-use cordless laparoscopic morcellator.
The Defendant, Tonglu Qianyan Medtech Co., Ltd., is a Chinese manufacturer of disposable medical products for laparoscopy, urology, orthopaedics, and gynaecology. The Defendant was exhibiting a "disposable morcellator" at the MEDICA trade fair in Düsseldorf (17-20 November 2025). The Applicant argued that the exhibited product looked identical to a product previously obtained from outside the UPC territory through an American distributor, which was manufactured by the Defendant. The Applicant suspected this product was a slavish copy of the LiNA Xcise™ and potentially infringed the patent. The Applicant contended that whether the product infringed the patent could only be determined by disassembling and analysing it, particularly with regard to the switch feature of claim 1.
The Applicant requested an order for prompt and effective provisional measures to preserve evidence of the alleged infringement, including an inspection by an independent expert at the Defendant's exhibition booth, without prior hearing of the Defendant. The application was based on Articles 60 UPCA and Rules 194(d), 196, 197, and 199 of the Rules of Procedure.
The Court granted the application, ordering an inspection and preservation of evidence procedure to be carried out by an independent expert at the MEDICA trade fair. The order included detailed provisions for: (I) the inspection procedure to identify whether the Defendant's product complies with features claimed in claims 1-6 of the patent; (II) seizure of the disposable morcellator and related documents; (III) preparation of a detailed description by the expert; (IV) confidentiality measures requiring all persons involved to keep facts confidential; (V) provision for the Defendant to comment on confidentiality interests; (VI) the Applicant bearing the costs of the inspection; (VII) potential penalty payments for culpable breach; and (VIII) revocation of measures if the Applicant does not bring main proceedings within 31 calendar days or 20 working days (whichever is longer) after disclosure of the expert's description.
The Defendant was given the right to request a review of the order within 30 days after execution of the measures (Art. 60(6) UPCA, R. 197.3 RoP) and the right to appeal within 15 days of service (Art. 73(2)(a) UPCA, R. 220.1(c) RoP). The order was issued by Presiding Judge Thomas (acting as judge-rapporteur), legally qualified judge Dr Thom, and legally qualified judge Gillet.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Düsseldorf (DE) Local Division. Understanding the court's reasoning in LiNA Medical AG vs Tonglu Qianyan Medtech Co., Ltd. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
PHOENIX CONTACT GmbH & Co. KGvsIndustria Lombarda Materiale Elettrico I.L.M.E. S.p.A. and ILME GmbH Elektrotechnische Handelsgesellschaft
This case concerned an infringement action regarding European Patent EP 3 602 692, accompanied by a revocation counterclaim. Following an out-of-court settlement, the plaintiff withdrew the infringement claim and the defendants withdrew the revocation counterclaim. The court allowed both withdrawals, terminated the proceedings, and addressed the refund of court fees, setting the value of the infringement claim at €750,000 and the revocation counterclaim at €1,125,000.
NovawellvsC-Kore Systems Limited
This is a procedural order from the Paris Local Division concerning an infringement action related to European Patent EP2265793, owned by C-Kore Systems Limited. Following a Saisie Order issued on 14 November 2023, the parties agreed on the composition of a confidentiality club to review seized documents containing trade secrets. The Court approved the parties' agreed list of persons, holding that while Rule 262A RoP requires at least one natural person from each party, parties may mutually agree to exclude natural persons from the parties themselves, provided the principle of fair trial is preserved.
Powell Gilbert LLP (Application for Public Access to the Register)vsEx Parte
Powell Gilbert LLP, as a member of the public, applied under Rule 262.1 RoP for access to written pleadings and evidence from concluded proceedings (UPC_CFI_131/2024) concerning EP3831283, a patent owned by Abbott Diabetes Care Inc. The main proceeding parties (Abbott, Sibio Technology Limited, and Umedwings Netherlands B.V.) opposed the application, arguing that an appeal was pending and that Powell Gilbert lacked a sufficiently specific interest. The Local Division The Hague granted the application, applying the criteria from the Court of Appeal's decision in Ocado v AutoStore, and also granted leave to appeal.
Daedalus Prime LLCvsXiaomi Communications Co., Ltd. & Others
This procedural order from the Local Division Hamburg concerns the bifurcation of infringement and revocation proceedings involving European Patent EP2792100. The Claimant Daedalus Prime LLC and Defendants Xiaomi Inc., Xiaomi Technology Netherlands B.V., and Xiaomi Technology Germany GmbH all favored referring the counterclaim for revocation to the Central Division Paris. The court referred the counterclaim for revocation to the Central Division Paris while continuing with the infringement action, scheduling the oral hearing not before early summer 2025.
SES-imagotag SAvsHanshow Technology Co. Ltd, Hanshow Germany GmbH, Hanshow France SAS, Hanshow Netherlands B.V.
This is a cost assessment decision by the Local Chamber Munich of the Unified Patent Court following the rejection of SES-imagotag SA's application for interim measures against four Hanshow group companies. The court assessed the recoverable costs of the prevailing respondents (Hanshow entities) at €200,000, applying a plausibility check rather than requiring minute-by-hour breakdowns, and rejecting the applicant's arguments regarding excessive representation and non-recoverable interpretation costs.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.